Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

244.02
+5.452.28%
Post-market: 245.501.48+0.61%16:48 EDT
Volume:550.54K
Turnover:134.37M
Market Cap:17.14B
PE:42.19
High:246.55
Open:241.83
Low:239.37
Close:238.57
Loading ...

Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System

MT Newswires Live
·
20 Mar

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
20 Mar

BRIEF-Insulet’s radiant trial demonstrates glycemic improvements with Omnipod® 5 automated insulin delivery system

Reuters
·
20 Mar

Insulet’s Radiant Trial Demonstrates Meaningful Glycemic Improvements With the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition From Multiple Daily Injections

THOMSON REUTERS
·
20 Mar

BRIEF-Insulet announces pricing of senior notes due 2033

Reuters
·
19 Mar

Insulet Corp - Prices $450 Million Senior Unsecured Notes Due 2033

THOMSON REUTERS
·
19 Mar

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey
·
19 Mar

Insulet Plans $450 Million Senior Notes Offering

MT Newswires Live
·
18 Mar

Insulet Corp - to Amend Credit Agreement, Extend Maturity to 2030

THOMSON REUTERS
·
18 Mar

Insulet Corp - Proceeds to Partially Terminate 0.375% Convertible Senior Notes Due 2026

THOMSON REUTERS
·
18 Mar

Insulet Launches Omnipod 5 Insulin Delivery System in Australia

MT Newswires Live
·
18 Mar

Insulet Corp - Expands Omnipod 5 to Four More International Markets

THOMSON REUTERS
·
18 Mar

Insulet- Omnipod 5 Automated Insulin Delivery System Commercially Available in Australia, Launching Soon in Belgium, Canada, Switzerland

THOMSON REUTERS
·
18 Mar

Insulet Expands Omnipod® 5 to Four More International Markets

Business Wire
·
18 Mar

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Business Wire
·
18 Mar

Insulet CTO Mark Field Departs for New Opportunities

TIPRANKS
·
18 Mar

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Simply Wall St.
·
12 Mar

Insulet to Host Investor Day on June 5, 2025

Business Wire
·
11 Mar

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
11 Mar

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Simply Wall St.
·
09 Mar